Krishgen BioSystems 2026 Calendar Theme Scientific progress is never sudden – it is cumulative. Every modern method, every assay, every therapeutic innovation, and every research workflow we rely on today has been shaped by decades of foundational discoveries. As an Indian manufacturer serving the global life sciences community, Krishgen BioSystems believes India’s scientific story deserves […]
The development and production of biotherapeutics, including monoclonal antibodies, recombinant proteins, and gene therapy vectors, require rigorous control of process- and product-related impurities. These impurities can influence the safety, efficacy, and stability of the final therapeutic product. As regulatory agencies increasingly emphasize the importance of critical quality attributes (CQAs), enzyme-linked immunosorbent assays (ELISAs) have emerged […]
Popular Targets for Bispecific Antibody Drugs Bispecific Antibody drugs have gained considerable popularity since the approval of blinatumomab. Currently, six bsAb drugs have been approved by the US FDA / EMA and over 180 are currently in clinical trials. BsAb simultaneously recognize different antigens or epitopes, resulting in a diverse range of therapeutic mechanisms. With a […]
Explore Krishgen’s blog for expert insights on ELISA assays, life science research, biotech innovations, laboratory best practices, and product updates designed to support scientists and research institutions.
